MORGAN STANLEY PLC/CALL/CENCORA/250/0.1/21.06.24

MORGAN STANLEY PLC/CALL/CENCORA/250/0.1/21.06.24 Stock

DE000MB8ATC1

Market Closed - Börse Stuttgart 14:14:16 2024-05-24 EDT
0.029 ^EUR	+866.67%

Current month	-92.93%
1 month	-93.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart CENCORA, INC.

Chart MORGAN STANLEY PLC/CALL/CENCORA/250/0.1/21.06.24

Latest news about CENCORA, INC.

Cencora Notifies Individuals Affected by Data Breach	05-24	MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	05-23
The market is good to go until Nvidia’s next quarterly results	05-23
Walgreens Boots Alliance Sells $400 Million of Cencora Shares	05-23	MT

More news

Quotes 5-day view

Date	Price	Change
24-05-24	0.029	+866.67%
24-05-23	0.003	-92.31%
24-05-22	0.039	+116.67%
24-05-21	0.018	-56.10%
24-05-20	0.041	-32.79%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 02:14 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	CENCORA, INC.
Issuer	Morgan Stanley
WKN	MB8ATC
ISIN	DE000MB8ATC1
Date issued	2023-07-04
Strike	250 $
Maturity	2024-06-21 (27 Days)
Parity	10 : 1
Emission price	0.25 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.95 €
Lowest since issue	0.001 €
Delta	0.06x
Omega	29.19
Premium	14.35x
Gearing	453.77x
Moneyness	0.8762
Difference Strike	31.11 $
Difference Strike %	+12.44%
Spread	0.029 €
Spread %	49.15%
Theoretical value	0.0445
Implied Volatility	29.52 %
Total Loss Probability	94.57 %
Intrinsic value	0.000000
Present value	0.0445
Break even	250.48 €
Theta	-0.02x
Vega	0.01x
Rho	0x

Company Profile

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

More about the company

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Cencora, Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

218.9 USD

Average target price

255.1 USD

Spread / Average Target

+16.56%

Consensus